-
Crude rises, stocks fall on fears over nascent Iran ceasefire
-
Waiting for DeepSeek: new model to test China's AI ambitions
-
You're being watched: Japan battles online abuse of athletes
-
US court expedites Anthropic's legal battle with Department of War
-
Badminton to trial synthetic shuttlecocks because of feather shortage
-
Firm, fast Augusta set to test golf's best in 90th Masters
-
BTS to kick off world tour after landmark Seoul comeback
-
Grand National had to change to survive, says former winning jockey
-
Maple syrup or nutella? PM Carney calls Canadian Artemis astronaut
-
Comedy duo Flight of the Conchords reunion gigs sell out in minutes
-
US-Iran truce enters second day as war flares in Lebanon
-
Trump blasts NATO after closed-door Rutte meeting
-
Houston, we have a problem ... with the toilet
-
Slot admits Liverpool in 'survival mode' in PSG defeat
-
Trump makes up with Sahel juntas, with eye on US interests
-
Tiger Woods drug records to be subpoenaed by prosecutors
-
England's Rai wins Par-3 Contest to risk Masters curse
-
Brazil's Chief Raoni backs Lula in elections
-
Trump to discuss leaving NATO in meeting with Rutte
-
Atletico punish 10-man Barcelona, take control of Champions League tie
-
Dominant PSG leave Liverpool right up against it in Champions League tie
-
Meta releases first new AI model since shaking up team
-
Tehran residents relieved but divided by Trump truce
-
Vance says up to Iran if it wants truce to 'fall apart' over Lebanon
-
US, Iran truce hangs in balance as war flares in Lebanon
-
Scale of killing in Lebanon 'horrific': UN rights chief
-
'Ketamine Queen' jailed for 15 years over Matthew Perry drugs
-
Betis earn draw in Europa League quarter-final at Braga
-
Buttler hits form with IPL fifty as Gujarat win last-ball thriller
-
'Total victory' or TACO? Trump faces questions on Iran deal
-
Medvedev thrashed at Monte Carlo as Zverev battles through
-
Trump to discuss leaving NATO in meeting with Rutte: White House
-
Five US multiple major champions seek first Masters win
-
Howell got McIlroy ball as kid and now joins him at Masters
-
Turkey puts 11 on trial for LGBT 'obscenity'
-
Augusta boss eyes tradition and innovation balance at Masters
-
In Trump war on Iran, tactical wins and long-term damage to US
-
Argentine MPs to debate watered-down glaciers protection
-
Brazilian police dog sniffs out 48 tons of marijuana in record bust
-
Leicester close to third tier after points deduction appeal dismissed
-
In the heart of Beirut, buildings in flames and charred cars
-
Dilemma over crossings as fate of Hormuz ships remains uncertain
-
Laurance 'becomes someone else' to nab Tour of the Basque Country stage win
-
Mediators to 'fragile' US-Iran truce urge restraint as violations reported
-
Laurance pips Arrieta to Tour of the Basque Country third stage win
-
US, Iran ceasefire sees Israel's war goals left hanging
-
'Unfinished business': Opponents anxious, bitter after Iran ceasefire
-
Dutch minister says not planning to bar Kanye West
-
France unveils rearmament boost to face Russia threat
-
Suspect remains silent in Swiss bar fire probe
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
CEO Chad Pawlak to deliver corporate update on AI-accelerated peptide platform and strategic growth initiatives
WOODLAND, CA / ACCESS Newswire / March 5, 2026 / Genvor, Inc. (OTCQB:GNVR) ("Genvor" or the "Company") is pleased to announce that Chief Executive Officer Chad Pawlak will be presenting at the National Investment Banking Association's (NIBA) 152nd Investment Conference in Fort Lauderdale, Florida on March 12, 2026.
The presentation will include a corporate update highlighting the Company's recent milestones, technology platform advancements and upcoming growth initiatives. Attendees and investors are encouraged to schedule one-on-one meetings with management during the conference.
NIBA's 152nd Investment Conference will be held March 11-12, 2026 at the Westin Fort Lauderdale Beach Resort. For more information or to register, please visit: https://nibas-152nd-investment-conference.events.accessnewswire.com/
About Genvor
Genvor, Inc. (OTCQB:GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health. Genvor's proprietary BioCypher platform designs peptides that enhance crop performance, reduce chemical inputs, and support human recovery and wellness. Through strategic partnerships and a dual-market commercialization model, Genvor is advancing peptide science from field to finish line. For more information, visit www.genvor.com.
About National Investment Banking Association
The National Investment Banking Association (NIBA) is a non-profit organization that has been serving the micro-cap and small-cap investment community for over 40 years. NIBA's 152nd Investment Conference website is available here: https://nibas-152nd-investment-conference.events.accessnewswire.com/
Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied. Genvor undertakes no obligation to update forward-looking statements except as required by applicable law.
For more information contact:
Investor Relations
Genvor Incorporated
[email protected]
www.genvor.com
Media
Carly Scaduto
[email protected]
SOURCE: Genvor, Inc.
View the original press release on ACCESS Newswire
J.Williams--AMWN